procainamide has been researched along with Arteriosclerosis, Coronary in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hahn, M | 1 |
Stamer, UM | 1 |
Luedi, MM | 1 |
Book, M | 1 |
Rieder, HU | 1 |
Stüber, F | 1 |
Otten, RF | 1 |
Dusa, AC | 1 |
Das, MK | 1 |
2 other studies available for procainamide and Arteriosclerosis, Coronary
Article | Year |
---|---|
ASA Status,
Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; | 2022 |
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy.
Topics: Anti-Arrhythmia Agents; Atropine; Brugada Syndrome; Cardiotonic Agents; Cholinesterase Inhibitors; C | 2007 |